These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 15475094)

  • 1. Do proton pump inhibitors increase the incidence of nosocomial pneumonia and related infectious complications when compared with histamine-2 receptor antagonists in critically ill trauma patients?
    Mallow S; Rebuck JA; Osler T; Ahern J; Healey MA; Rogers FB
    Curr Surg; 2004; 61(5):452-8. PubMed ID: 15475094
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stress ulcer prophylaxis in critically ill patients: a randomized controlled trial.
    Kantorova I; Svoboda P; Scheer P; Doubek J; Rehorkova D; Bosakova H; Ochmann J
    Hepatogastroenterology; 2004; 51(57):757-61. PubMed ID: 15143910
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proton pump inhibitors for the prevention of stress-related mucosal disease in critically-ill patients: a meta-analysis.
    Pongprasobchai S; Kridkratoke S; Nopmaneejumruslers C
    J Med Assoc Thai; 2009 May; 92(5):632-7. PubMed ID: 19459523
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Therapy with gastric acidity inhibitors increases the risk of acute gastroenteritis and community-acquired pneumonia in children.
    Canani RB; Cirillo P; Roggero P; Romano C; Malamisura B; Terrin G; Passariello A; Manguso F; Morelli L; Guarino A;
    Pediatrics; 2006 May; 117(5):e817-20. PubMed ID: 16651285
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The influence of feeding on gastric acid suppression in Helicobacter pylori-positive patients treated with a proton pump inhibitor or an H2-receptor antagonist after bleeding from a gastric ulcer.
    Ozawa T; Yoshikawa N; Tomita T; Akita Y; Mitamura K
    J Gastroenterol; 2003; 38(9):844-8. PubMed ID: 14564629
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proton pump inhibitors vs. histamine 2 receptor antagonists for stress-related mucosal bleeding prophylaxis in critically ill patients: a meta-analysis.
    Barkun AN; Bardou M; Pham CQ; Martel M
    Am J Gastroenterol; 2012 Apr; 107(4):507-20; quiz 521. PubMed ID: 22290403
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of H2-receptor antagonist and proton pump inhibitor on microbial proliferation in the stomach.
    Wang K; Lin HJ; Perng CL; Tseng GY; Yu KW; Chang FY; Lee SD
    Hepatogastroenterology; 2004; 51(59):1540-3. PubMed ID: 15362796
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Review article: prevention of stress-related mucosal bleeding with proton-pump inhibitors.
    Maton PN
    Aliment Pharmacol Ther; 2005 Dec; 22 Suppl 3():45-52. PubMed ID: 16303037
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Iatrogenic gastric acid suppression and the risk of nosocomial Clostridium difficile infection.
    Howell MD; Novack V; Grgurich P; Soulliard D; Novack L; Pencina M; Talmor D
    Arch Intern Med; 2010 May; 170(9):784-90. PubMed ID: 20458086
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Heartburn-dominant, uninvestigated dyspepsia: a comparison of 'PPI-start' and 'H2-RA-start' management strategies in primary care--the CADET-HR Study.
    Armstrong D; Veldhuyzen van Zanten SJ; Barkun AN; Chiba N; Thomson AB; Smyth S; Sinclair P; Chakraborty B; White RJ;
    Aliment Pharmacol Ther; 2005 May; 21(10):1189-202. PubMed ID: 15882239
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Addition of a H2 receptor antagonist to PPI improves acid control and decreases nocturnal acid breakthrough.
    Mainie I; Tutuian R; Castell DO
    J Clin Gastroenterol; 2008 Jul; 42(6):676-9. PubMed ID: 18496394
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Proton pump inhibitors are associated with reduced incidence of dysplasia in Barrett's esophagus.
    El-Serag HB; Aguirre TV; Davis S; Kuebeler M; Bhattacharyya A; Sampliner RE
    Am J Gastroenterol; 2004 Oct; 99(10):1877-83. PubMed ID: 15447744
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term gastroesophageal reflux disease therapy improves reflux symptoms in elderly patients: five-year prospective study in community medicine.
    Miyamoto M; Haruma K; Kuwabara M; Nagano M; Okamoto T; Tanaka M
    J Gastroenterol Hepatol; 2007 May; 22(5):639-44. PubMed ID: 17444849
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Proton pump inhibitor prophylaxis increases the risk of nosocomial pneumonia in patients with an intracerebral hemorrhagic stroke.
    Ran L; Khatibi NH; Qin X; Zhang JH
    Acta Neurochir Suppl; 2011; 111():435-9. PubMed ID: 21725797
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of H2-receptor antagonists in the pathogenesis of nosocomial pneumonia in mechanically ventilated patients.
    Trofe J; Peterson AM
    Pharmacotherapy; 1998; 18(4):808-15. PubMed ID: 9692653
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stress-related mucosal bleeding in critically ill oncology patients.
    Bruno JJ; Canada TW; Wakefield CD; Nates JL
    J Oncol Pharm Pract; 2009 Mar; 15(1):9-16. PubMed ID: 18753185
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Histamine-2 receptor antagonists vs proton pump inhibitors on gastrointestinal tract hemorrhage and infectious complications in the intensive care unit.
    MacLaren R; Reynolds PM; Allen RR
    JAMA Intern Med; 2014 Apr; 174(4):564-74. PubMed ID: 24535015
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A case-control study on adverse effects: H2 blocker or proton pump inhibitor use and risk of vitamin B12 deficiency in older adults.
    Valuck RJ; Ruscin JM
    J Clin Epidemiol; 2004 Apr; 57(4):422-8. PubMed ID: 15135846
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Histamine 2 receptor antagonists vs intravenous proton pump inhibitors in a pediatric intensive care unit: a comparison of gastric pH.
    Tofil NM; Benner KW; Fuller MP; Winkler MK
    J Crit Care; 2008 Sep; 23(3):416-21. PubMed ID: 18725049
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Potential influence of antisecretory therapy on the development of Candida-associated intraabdominal infection.
    Cat TB; Charash W; Hebert J; Marden BT; Corbett SM; Ahern J; Rebuck JA
    Ann Pharmacother; 2008 Feb; 42(2):185-91. PubMed ID: 18212256
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.